COVID-19 Vaccine Delivery Methods Study

This study is looking at how different ways of giving the COMIRNATY® mRNA COVID-19 vaccine affect your body's immune response. Researchers want to compare a needle-free injection system to the usual shot with a needle and syringe. They will measure immune responses for nine months to see if one method works better. You might be able to join if you are a healthy adult between 18 and 50 years old. The study plans to enroll 40 people, but its current status is unclear.

Study design
This interventional study plans to enroll 40 healthy volunteers.
What's involved
You would need to attend all scheduled visits, receive the vaccine, and complete laboratory tests.
Compensation
Not stated in the trial record.
Follow-up
Your immune responses will be measured for nine months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06919796

mRNA Covid-19 Vaccine Immune Response Comparisons Using Different Delivery Routes

Not Yet Recruiting
PHASE2Ages 18–50InterventionalTreatment
PharmaJet, Inc.
~40 participants
Updated 2025-04-15 on ClinicalTrials.gov
What's tested:COMIRNATY®

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Primary Objective
Measured over Nine months
Evaluate Immune Responses Following mRNA COVID-19 Vaccine Administration Through Different Delivery Routes in Healthy Volunteers
SARS CoV-2
1 sites across 1 states
Georgia1

Opens a ready-to-send draft in your own email app — review before sending.

  • Primary ObjectiveNine months

    In 40 participants response rate, and magnitude of SARS-CoV-2-specific antibody neutralization titers will be measured at Day 30 and Month 6-9 after vaccination